
Delivering RNA therapies.
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression. Sixfold Bioscience is a Y Combinator company (Winter 2018). YC-listed status: Active.